Skip to content
Find a Provider
Shreedevi Pandya, D.P.T., M.S.

Shreedevi Pandya, D.P.T., M.S.

Contact

Call Center (585) 276-3000

About Me

Professional Background

Shree Pandya, PT, DPT, MS is Associate Professor of Neurology in the School of Medicine and Dentistry at the University of Rochester. Dr Pandya is a clinician, researcher and educator working in the area of inherited neuromuscular disorders for the past thirty years. She has also worked extensively ...
Shree Pandya, PT, DPT, MS is Associate Professor of Neurology in the School of Medicine and Dentistry at the University of Rochester. Dr Pandya is a clinician, researcher and educator working in the area of inherited neuromuscular disorders for the past thirty years. She has also worked extensively with patient organizations – serving as "Ask the Expert" for the Muscular Dystrophy Association (MDA), co –writing a booklet on physical therapy for the Facioscapulohumeral dystrophy (FSHD) Society and helping with physical therapy related web content for the Myotonic Dystrophy Foundation.
Dr. Pandya has served on national (American Academy of Neurology) and international (European Neuromuscular Center) panels to develop evidence based and consensus based guidelines for management of patients with various neuromuscular disorders. Currently she serves on the steering committee and is co-chair of the Rehab panel for the update of the CDC funded care considerations for Duchenne muscular dystrophy. She is Co-PI in New York for the Muscular Dystrophy Surveillance Tracking and Research Network (MDSTARNet) funded by the Centers for Disease Control ( 2006-present).

Faculty Appointments

Associate Professor (Service) (Part-Time) - Department of Neurology, NMD (SMD)

Credentials

Education

Doctor of Physical Therapy | Suny Upstate Medical University. 2010

MS | University of Wisconsin-Madison. Physical Therapy. 1979

Awards

Research Award, Pediatric Section, American Physical Therapy Association 2004

Outstanding Physiotherapist, Class of 1969 Bombay Branch, Indian Association of Physiotherapy 1969

Publications

Journal Articles

Rasch analysis of the Pediatric Evaluation of Disability Inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy.

Pasternak A, Sideridis G, Fragala-Pinkham M, Glanzman AM, Montes J, Dunaway S, Salazar R, Quigley J, Pandya S, O'Riley S, Greenwood J, Chiriboga C, Finkel R, Tennekoon G, Martens WB, McDermott MP, Szelag Fournier H, Madabusi L, Harrington T, Cruz RE, LaMarca NM, Videon NM, De Vivo DC, Darras BT, ,

Muscle & nerve.. 2016 December 54 (6):1097-1107. Epub 10/06/2016.

Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.

Lamb MM, West NA, Ouyang L, Yang M, Weitzenkamp D, James K, Ciafaloni E, Pandya S, DiGuiseppi C,

The Journal of pediatrics.. 2016 June 173 :207-213.e3. Epub 03/30/2016.

Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.

Sansone VA, Burge J, McDermott MP, Smith PC, Herr B, Tawil R, Pandya S, Kissel J, Ciafaloni E, Shieh P, Ralph JW, Amato A, Cannon SC, Trivedi J, Barohn R, Crum B, Mitsumoto H, Pestronk A, Meola G, Conwit R, Hanna MG, Griggs RC,

Neurology.. 2016 April 1286 (15):1408-1416. Epub 02/10/2016.

Myotonic dystrophy health index: Correlations with clinical tests and patient function.

Heatwole C, Bode R, Nicholas Johnson , Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, McDermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT

Muscle & nerve.. 2016 February 53 (2):183-90. Epub 12/29/2015.

Health services received by individuals with duchenne/becker muscular dystrophy.

Pandya SK, Campbell KA, Andrews JG, Meaney FJ, Ciafaloni E

Muscle & nerve.. 2016 February 53 (2):191-7. Epub 12/29/2015.

Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.

Ciafaloni E, Kumar A, Liu K, Pandya S, Westfield C, Fox DJ, Caspers Conway KM, Cunniff C, Mathews K, West N, Romitti PA, McDermott MP

Journal of pediatric rehabilitation medicine.. 2016 9 (1):5-11. Epub 1900 01 01.

Physical therapy services received by individuals with spinal muscular atrophy (SMA).

Dunaway S, Montes J, McDermott MP, Martens W, Neisen A, Glanzman AM, Pasternak A, Riley S, Sproule D, Chiriboga C, Finkel R, Tennekoon G, Darras B, De Vivo D, Pandya S

Journal of pediatric rehabilitation medicine.. 2016 9 (1):35-44. Epub 1900 01 01.

Rehabilitative technology use among individuals with Duchenne/Becker muscular dystrophy.

Pandya S, Andrews J, Campbell K, Meaney FJ

Journal of pediatric rehabilitation medicine.. 2016 9 (1):45-53. Epub 1900 01 01.

Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.

Montes J, Glanzman AM, Mazzone ES, Martens WB, Dunaway S, Pasternak A, Riley SO, Quigley J, Pandya S, De Vivo DC, Kaufmann P, Chiriboga CA, Finkel RS, Tennekoon GI, Darras BT, Pane M, Mercuri E, Mcdermott MP,

Muscle & nerve.. 2015 December 52 (6):942-7. Epub 10/10/2015.

Risk Factors for First Fractures Among Males With Duchenne or Becker Muscular Dystrophy.

James KA, Cunniff C, Apkon SD, Mathews K, Lu Z, Holtzer C, Pandya S, Ciafaloni E, Miller L

Journal of pediatric orthopedics.. 2015 September 35 (6):640-4. Epub 1900 01 01.

Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Tawil R, Kissel JT, Heatwole C, Pandya S, Gronseth G, Benatar M

Neurology.. 2015 July 2885 (4):357-64. Epub 1900 01 01.

Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies.

Pettygrove S, Lu Z, Andrews JG, Meaney FJ, Sheehan DW, Price ET, Fox DJ, Pandya S, Ouyang L, Apkon SD, Powis Z, Cunniff C

Muscle & nerve.. 2014 June 49 (6):814-21. Epub 1900 01 01.

Rasch analysis of clinical outcome measures in spinal muscular atrophy.

Cano SJ, Mayhew A, Glanzman AM, Krosschell KJ, Swoboda KJ, Main M, Steffensen BF, Bérard C, Girardot F, Payan CA, Mercuri E, Mazzone E, Elsheikh B, Florence J, Hynan LS, Iannaccone ST, Nelson LL, Pandya S, Rose M, Scott C, Sadjadi R, Yore MA, Joyce C, Kissel JT,

Muscle & nerve.. 2014 March 49 (3):422-30. Epub 07/26/2013.

Splicing biomarkers of disease severity in myotonic dystrophy.

Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson M, Moxley RT, Thornton CA

Annals of neurology.. 2013 December 74 (6):862-72. Epub 1900 01 01.

Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.

Barber BJ, Andrews JG, Lu Z, West NA, Meaney FJ, Price ET, Gray A, Sheehan DW, Pandya S, Yang M, Cunniff C

The Journal of pediatrics.. 2013 October 163 (4):1080-4.e1. Epub 07/15/2013.

Corticosteroids in Duchenne muscular dystrophy: major variations in practice.

Griggs RC, Herr BE, Reha A, Elfring G, Atkinson L, Cwik V, McColl E, Tawil R, Pandya S, McDermott MP, Bushby K

Muscle & nerve.. 2013 July 48 (1):27-31. Epub 04/25/2013.

Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.

Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R

Neuromuscular disorders : NMD.. 2013 April 23 (4):306-12. Epub 02/11/2013.

Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.

Statland JM, Bundy BN, Wang Y, Rayan DR, Trivedi JR, Sansone VA, Salajegheh MK, Venance SL, Ciafaloni E, Matthews E, Meola G, Herbelin L, Griggs RC, Barohn RJ, Hanna MG,

JAMA.. 2012 October 3308 (13):1357-65. Epub 1900 01 01.

A quantitative measure of handgrip myotonia in non-dystrophic myotonia.

Statland JM, Bundy BN, Wang Y, Trivedi JR, Raja Rayan D, Herbelin L, Donlan M, McLin R, Eichinger KJ, Findlater K, Dewar L, Pandya S, Martens WB, Venance SL, Matthews E, Amato AA, Hanna MG, Griggs RC, Barohn RJ,

Muscle & nerve.. 2012 October 46 (4):482-9. Epub 1900 01 01.

Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Nabukera SK, Romitti PA, Campbell KA, Meaney FJ, Caspers KM, Mathews KD, Hockett Sherlock SM, Puzhankara S, Cunniff C, Druschel CM, Pandya S, Matthews DJ, Ciafaloni E, Starnet M

Journal of child neurology.. 2012 June 27 (6):734-40. Epub 12/07/2011.

Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK.

Sadjadi R, Vincent KA, Carr AJ, Walburn J, Brooks VL, Pandya S, Kissel JT, Jackson CE, Rose MR,

Health and quality of life outcomes.. 2011 December 169 :114. Epub 12/16/2011.

Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy.

Holtzer C, Meaney FJ, Andrews J, Ciafaloni E, Fox DJ, James KA, Lu Z, Miller L, Pandya S, Ouyang L, Cunniff C

Genetics in medicine : official journal of the American College of Medical Genetics.. 2011 November 13 (11):942-7. Epub 1900 01 01.

A randomized, pilot trial of etanercept in dermatomyositis.

Annals of neurology.. 2011 September 70 (3):427-36. Epub 06/17/2011.

An interactive voice response diary for patients with non-dystrophic myotonia.

Statland JM, Wang Y, Richesson R, Bundy B, Herbelin L, Gomes J, Trivedi J, Venance S, Amato A, Hanna M, Griggs R, Barohn RJ,

Muscle & nerve.. 2011 July 44 (1):30-5. Epub 1900 01 01.

Palliative care services in families of males with Duchenne muscular dystrophy.

Arias R, Andrews J, Pandya S, Pettit K, Trout C, Apkon S, Karwoski J, Cunniff C, Matthews D, Miller T, Davis MF, Meaney FJ

Muscle & nerve.. 2011 July 44 (1):93-101. Epub 1900 01 01.

Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT

Archives of neurology.. 2011 January 68 (1):37-44. Epub 09/13/2010.

Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy.

Matthews DJ, James KA, Miller LA, Pandya S, Campbell KA, Ciafaloni E, Mathews KD, Miller TM, Cunniff C, Meaney FJ, Druschel CM, Romitti PA, Fox DJ

Journal of child neurology.. 2010 November 25 (11):1319-24. Epub 03/05/2010.

What determines quality of life in inclusion body myositis?

Sadjadi R, Rose MR,

Journal of neurology, neurosurgery, and psychiatry.. 2010 October 81 (10):1164-6. Epub 07/02/2010.

Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.

Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K

Journal of child neurology.. 2010 September 25 (9):1116-29. Epub 06/25/2010.

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C,

The Lancet. Neurology.. 2010 February 9 (2):177-89. Epub 11/27/2009.

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C,

The Lancet. Neurology.. 2010 January 9 (1):77-93. Epub 11/27/2009.

Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Ciafaloni E, Fox DJ, Pandya S, Westfield CP, Puzhankara S, Romitti PA, Mathews KD, Miller TM, Matthews DJ, Miller LA, Cunniff C, Druschel CM, Moxley RT

The Journal of pediatrics.. 2009 September 155 (3):380-5. Epub 04/25/2009.

Clinical outcome measures in spinal muscular atrophy.

Montes J, Gordon AM, Pandya S, De Vivo DC, Kaufmann P

Journal of child neurology.. 2009 August 24 (8):968-78. Epub 06/09/2009.

Mutation analysis in a population-based cohort of boys with Duchenne or Becker muscular dystrophy.

Cunniff C, Andrews J, Meaney FJ, Mathews KD, Matthews D, Ciafaloni E, Miller TM, Bodensteiner JB, Miller LA, James KA, Druschel CM, Romitti PA, Pandya S

Journal of child neurology.. 2009 April 24 (4):425-30. Epub 12/12/2008.

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.

Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR

Annals of neurology.. 2008 May 63 (5):561-71. Epub 1900 01 01.

Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity.

Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L,

Muscle & nerve.. 2008 April 37 (4):473-6. Epub 1900 01 01.

Facioscapulohumeral dystrophy.

Pandya S, King WM, Tawil R

Physical therapy.. 2008 January 88 (1):105-13. Epub 11/06/2007.

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).

Moxley RT, Logigian EL, Martens WB, Annis CL, Pandya S, Moxley RT, Barbieri CA, Dilek N, Wiegner AW, Thornton CA

Muscle & nerve.. 2007 September 36 (3):320-8. Epub 1900 01 01.

Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.

Logigian EL, Ciafaloni E, Quinn LC, Dilek N, Pandya S, Moxley RT, Thornton CA

Muscle & nerve.. 2007 April 35 (4):479-85. Epub 1900 01 01.

The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.

Miller LA, Romitti PA, Cunniff C, Druschel C, Mathews KD, Meaney FJ, Matthews D, Kantamneni J, Feng ZF, Zemblidge N, Miller TM, Andrews J, Fox D, Ciafaloni E, Pandya S, Montgomery A, Kenneson A

Birth defects research. Part A, Clinical and molecular teratology.. 2006 November 76 (11):793-7. Epub 1900 01 01.

Limb-girdle muscular dystrophy in the United States.

Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, Brown CA, Michele DE, Piccolo F, Winder TL, Stence A, Barresi R, King N, King W, Florence J, Campbell KP, Fenichel GM, Stedman HH, Kissel JT, Griggs RC, Pandya S, Mathews KD, Pestronk A, Serrano C, Darvish D, Mendell JR

Journal of neuropathology and experimental neurology.. 2006 October 65 (10):995-1003. Epub 1900 01 01.

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Moxley RT, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, Baumbach L, McDonald C, Sussman M, Wade C, ,

Neurology.. 2005 January 1164 (1):13-20. Epub 1900 01 01.

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.

Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R,

Neurology.. 2001 October 2357 (8):1434-40. Epub 1900 01 01.

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy.

Fenichel GM, Griggs RC, Kissel J, Kramer TI, Mendell JR, Moxley RT, Pestronk A, Sheng K, Florence J, King WM, Pandya S, Robison VD, Wang H

Neurology.. 2001 April 2456 (8):1075-9. Epub 1900 01 01.

Quantitative assessment of motor fatigue and strength in MS.

Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, McDermott MP, Goodman AD

Neurology.. 1999 September 1153 (4):743-50. Epub 1900 01 01.

Physical Therapists in the Study of Genetic Disorders. (Invited Submission) for Physical Therapy and the New Genetics: Challenge for the 21st Century.

Pandya S.

PT Magazine. 1999; : 86-87.

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R

Neurology.. 1998 May 50 (5):1402-6. Epub 1900 01 01.

A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Neurology.. 1997 January 48 (1):38-46. Epub 1900 01 01.

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC

Neurology.. 1997 January 48 (1):46-9. Epub 1900 01 01.

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D

Annals of neurology.. 1996 June 39 (6):744-8. Epub 1900 01 01.

Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Personius KE, Pandya S, King WM, Tawil R, McDermott MP

Physical therapy.. 1994 March 74 (3):253-63. Epub 1900 01 01.

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC

Neurology.. 1994 March 44 (3 Pt 1):442-6. Epub 1900 01 01.

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J

Neurology.. 1993 March 43 (3 Pt 1):520-7. Epub 1900 01 01.

Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy.

Florence JM, Pandya S, King WM, Robison JD, Baty J, Miller JP, Schierbecker J, Signore LC

Physical therapy.. 1992 February 72 (2):115-22; discussion 122-6. Epub 1900 01 01.

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.

Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W

Neurology.. 1991 December 41 (12):1874-7. Epub 1900 01 01.

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.

Fenichel GM, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L

Archives of neurology.. 1991 June 48 (6):575-9. Epub 1900 01 01.

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.

Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP

Archives of neurology.. 1991 April 48 (4):383-8. Epub 1900 01 01.

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J

The New England journal of medicine.. 1989 June 15320 (24):1592-7. Epub 1900 01 01.

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, King WM, Pandya S, Robison J, Schierbecker J

Neurology.. 1989 April 39 (4):475-81. Epub 1900 01 01.

Randomized controlled trial of testosterone in myotonic dystrophy.

Griggs RC, Pandya S, Florence JM, Brooke MH, Kingston W, Miller JP, Chutkow J, Herr BE, Moxley RT

Neurology.. 1989 February 39 (2 Pt 1):219-22. Epub 1900 01 01.

Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.

Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, Moxley RT, Park JH, Provine MA, Florence J, Kaiser KK

Muscle & nerve.. 1988 November 11 (11):1164-8. Epub 1900 01 01.

Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls.

Mendell JR, Province MA, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, Kaiser KK, King W, Robison J

Archives of neurology.. 1987 August 44 (8):808-11. Epub 1900 01 01.

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley RT, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L

Archives of neurology.. 1987 August 44 (8):812-7. Epub 1900 01 01.

Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine.

Moxley RT, Brooke MH, Fenichel GM, Mendell JR, Griggs RC, Miller JP, Province MA, Patterson V

Muscle & nerve.. 1987 January 10 (1):22-33. Epub 1900 01 01.

Reliability of goniometric measurements in patients with Duchenne muscular dystrophy.

Pandya S, Florence JM, King WM, Robison JD, Oxman M, Province MA

Physical therapy.. 1985 September 65 (9):1339-42. Epub 1900 01 01.

Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.

Mendell JR, Griggs RC, Moxley RT, Fenichel GM, Brooke MH, Miller JP, Province MA, Dodson WE

Muscle & nerve.. 1984 September 7 (7):535-41. Epub 1900 01 01.

Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures.

Florence JM, Pandya S, King WM, Robison JD, Signore LC, Wentzell M, Province MA

Physical therapy.. 1984 January 64 (1):41-5. Epub 1900 01 01.

Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA

Muscle & nerve.. 1983 February 6 (2):91-103. Epub 1900 01 01.

Clinical trial in Duchenne dystrophy. I. The design of the protocol.

Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ

Muscle & nerve.. 1981 4 (3):186-97. Epub 1900 01 01.

Treatment of myopathic carnitine deficiency: quantitation of response to prednisone and carnitine.

Griggs RC, Pandya S, Moxley RT, Forbes G, VanDyke DH, Pearce FJ

Transactions of the American Neurological Association.. 1981 106 :199-202. Epub 1900 01 01.

Books

Introduction to Physical Therapy, 3rd ed. (2007)

Chapter: Physical Therapy for Neuromuscular Conditions

Authors: Pandya S

Publisher: Mosby 2007

Meeting Physical Therapy Needs of Children (2005)

Chapter: Case Study: Duchenne Muscular Dystrophy

Authors: Pandya, S

Publisher: FA Davis 2005

Myotonic Dystrophy: Present Managment, Future Therapy (2004)

Chapter: Therapeutic Trials

Authors: Moxley RT, Pandya S

Publisher: Oxford University Press 2004

Introduction to Physical Therapy, 2nd ed. (2001)

Chapter: Physical Therapy for Neuromuscular Conditions

Authors: Pandya, S

Publisher: Mosby 2001

Introduction to Physical Therapy (1996)

Chapter: Neurological Physical Therapy

Authors: Pandya, S

Publisher: Mosby 1996